178 related articles for article (PubMed ID: 25541715)
1. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Fallahi M; Amelio AL; Cleveland JL; Rounbehler RJ
PLoS One; 2014; 9(12):e115517. PubMed ID: 25541715
[TBL] [Abstract][Full Text] [Related]
2. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.
Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ
Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143
[TBL] [Abstract][Full Text] [Related]
3. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
6. Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer.
Lee HH; Son YJ; Lee WH; Park YW; Chae SW; Cho WJ; Kim YM; Choi HJ; Choi DH; Jung SW; Min YJ; Park SE; Lee BJ; Cha HJ; Park JW
Int J Cancer; 2010 Apr; 126(8):1817-1827. PubMed ID: 19697322
[TBL] [Abstract][Full Text] [Related]
7. Roles of Tristetraprolin in Tumorigenesis.
Park JM; Lee TH; Kang TH
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380668
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.
Al-Souhibani N; Al-Ahmadi W; Hesketh JE; Blackshear PJ; Khabar KS
Oncogene; 2010 Jul; 29(29):4205-15. PubMed ID: 20498646
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.
Lee JY; Kim HJ; Yoon NA; Lee WH; Min YJ; Ko BK; Lee BJ; Lee A; Cha HJ; Cho WJ; Park JW
Nucleic Acids Res; 2013 Jun; 41(11):5614-25. PubMed ID: 23595149
[TBL] [Abstract][Full Text] [Related]
11. The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells.
Dong F; Li C; Wang P; Deng X; Luo Q; Tang X; Xu L
Exp Cell Res; 2018 Jun; 367(1):89-96. PubMed ID: 29577897
[TBL] [Abstract][Full Text] [Related]
12. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
13. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
14. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.
Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y
BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669
[TBL] [Abstract][Full Text] [Related]
15. The role of RNA-binding protein tristetraprolin in cancer and immunity.
Guo J; Qu H; Chen Y; Xia J
Med Oncol; 2017 Nov; 34(12):196. PubMed ID: 29124478
[TBL] [Abstract][Full Text] [Related]
16. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
17. Identification of an AP1-ZFP36 Regulatory Network Associated with Breast Cancer Prognosis.
Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
[TBL] [Abstract][Full Text] [Related]
18. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
[TBL] [Abstract][Full Text] [Related]
19. Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.
Hitti E; Bakheet T; Al-Souhibani N; Moghrabi W; Al-Yahya S; Al-Ghamdi M; Al-Saif M; Shoukri MM; Lánczky A; Grépin R; Győrffy B; Pagès G; Khabar KS
Cancer Res; 2016 Jul; 76(14):4068-80. PubMed ID: 27197193
[TBL] [Abstract][Full Text] [Related]
20. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM
Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
